289 related articles for article (PubMed ID: 16310443)
1. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
Cheung EW; Chay GW; Ma ES; Cheung YF
Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
[TBL] [Abstract][Full Text] [Related]
3. Coagulation abnormalities and liver function after hemi-Fontan and Fontan procedures - the importance of hemodynamics in the early postoperative period.
Procelewska M; Kolcz J; Januszewska K; Mroczek T; Malec E
Eur J Cardiothorac Surg; 2007 May; 31(5):866-72. PubMed ID: 17329113
[TBL] [Abstract][Full Text] [Related]
4. Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion.
Odegard KC; Zurakowski D; DiNardo JA; Castro RA; McGowan FX; Neufeld EJ; Laussen PC
J Thorac Cardiovasc Surg; 2009 Apr; 137(4):934-41. PubMed ID: 19327521
[TBL] [Abstract][Full Text] [Related]
5. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic changes following the modified Fontan operation (total cavopulmonary connection).
Rauch R; Ries M; Hofbeck M; Buheitel G; Singer H; Klinge J
Thromb Haemost; 2000 May; 83(5):678-82. PubMed ID: 10823261
[TBL] [Abstract][Full Text] [Related]
7. Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children.
Rask O; Hanséus K; Ljung R; Strandberg K; Berntorp E
Cardiol Young; 2009 Apr; 19(2):152-8. PubMed ID: 19195416
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
9. Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders.
Cromme-Dijkhuis AH; Hess J; Hählen K; Henkens CM; Bink-Boelkens MT; Eygelaar AA; Bos E
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1126-32. PubMed ID: 8246550
[TBL] [Abstract][Full Text] [Related]
10. Liver and cardiac function in the long term after Fontan operation.
Camposilvan S; Milanesi O; Stellin G; Pettenazzo A; Zancan L; D'Antiga L
Ann Thorac Surg; 2008 Jul; 86(1):177-82. PubMed ID: 18573420
[TBL] [Abstract][Full Text] [Related]
11. Coagulation factor abnormalities after the Fontan procedure and its modifications.
Jahangiri M; Shore D; Kakkar V; Lincoln C; Shinebourne E
J Thorac Cardiovasc Surg; 1997 Jun; 113(6):989-92; discussion 992-3. PubMed ID: 9202678
[TBL] [Abstract][Full Text] [Related]
12. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
Ostrow AM; Freeze H; Rychik J
Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
[TBL] [Abstract][Full Text] [Related]
13. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
Cheung YF; Chay GW; Chiu CS; Cheng LC
Int J Cardiol; 2005 Jul; 102(3):509-13. PubMed ID: 16004898
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure.
Gupta A; Daggett C; Behera S; Ferraro M; Wells W; Starnes V
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1664-9. PubMed ID: 15173721
[TBL] [Abstract][Full Text] [Related]
15. Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up.
Chaloupecký V; Svobodová I; Hadacová I; Tomek V; Hucín B; Tláskal T; Janousek J; Reich O; Skovránek J
Heart; 2005 Jan; 91(1):73-9. PubMed ID: 15604339
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure.
Tomkiewicz-Pajak L; Hoffman P; Trojnarska O; Lipczyńska M; Podolec P; Undas A
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1284-90. PubMed ID: 23891464
[TBL] [Abstract][Full Text] [Related]
17. Increased vascular endothelial growth factor in patients with cyanotic congenital heart diseases may not be normalized after a Fontan type operation.
Suda K; Matsumura M; Miyanish S; Uehara K; Sugita T; Matsumoto M
Ann Thorac Surg; 2004 Sep; 78(3):942-6; discussion 946-7. PubMed ID: 15337024
[TBL] [Abstract][Full Text] [Related]
18. Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis.
Alphonso N; Baghai M; Sundar P; Tulloh R; Austin C; Anderson D
Eur J Cardiothorac Surg; 2005 Oct; 28(4):529-35. PubMed ID: 16135410
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease.
Turner-Gomes SO; Andrew M; Coles J; Trusler GA; Williams WG; Rabinovitch M
J Thorac Cardiovasc Surg; 1992 Jan; 103(1):87-97. PubMed ID: 1728719
[TBL] [Abstract][Full Text] [Related]
20. Specific issues after extracardiac fontan operation: ventricular function, growth potential, arrhythmia, and thromboembolism.
Chowdhury UK; Airan B; Kothari SS; Talwar S; Saxena A; Singh R; Subramaniam GK; Pradeep KK; Patel CD; Venugopal P
Ann Thorac Surg; 2005 Aug; 80(2):665-72. PubMed ID: 16039223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
